Sign in or register to see full information and data.

Studies / CAVD 235


Study information

Grant Affiliation:Weiss: Protection by Neutralizing Antibodies
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2008-08-21
Study Made Public:2012-06-15


Weiss mAbs potency


CAVD 235 is a monoclonal antibody study to characterize mAbs isolated and produced from IgG+ memory B cells of non-clade B HIV-1 infected donors, using a representative panel of HIV-1 primary isolates.


No Products used in study

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.